Diagnosis and office-based treatment of urinary incontinence in adults. Part two: Treatment

Therapeutic Advances in Urology

Volumn 5, Issue 4, 2013, Pages 189-200

  Cameron, Anne P ^a   Jimbo, Masahito ^b   Heidelbaugh, Joel J ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Adrenergic beta 3 Receptor Agonists; bladder retraining; lower urinary tract symptoms; muscarinic antagonists; overactive urinary bladder; pelvic floor physical therapy; pessaries; stress urinary incontinence

Indexed keywords

BULKING AGENT; DARIFENACIN; FESOTERODINE; MIRABEGRON; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; SOLIFENACIN; TOLTERODINE; TROSPIUM CHLORIDE;

ABSORBENT PAD; BLADDER SPHINCTER PROSTHESIS; BLOOD PRESSURE; CLINICAL FEATURE; CONDOM CATHETER; CONSERVATIVE TREATMENT; FLUID THERAPY; HEADACHE; HUMAN; MEDICAL DEVICE COMPLICATION; MICTURITION; MIXED INCONTINENCE; NEUROLOGICAL THERAPEUTIC DEVICE; OVERACTIVE BLADDER; PENILE CLAMP; PHYSIOTHERAPY; PRIORITY JOURNAL; REVIEW; RHINOPHARYNGITIS; SIDE EFFECT; STRESS INCONTINENCE; URETHRAL INSERT; URINARY TRACT INFECTION; URINE INCONTINENCE; UROLOGICAL EQUIPMENT; VAGINA PESSARY; WEIGHT REDUCTION;

EID: 84880875725     PISSN: 17562872     EISSN: 17562880     Source Type: Journal    
DOI: 10.1177/1756287213495100     Document Type: Review

References (52)

1. Abrams P. Andersson K. Birder L. Brubaker L. Cardozo L. Chapple C. for the Members of Committees and Fourth International Consultation on Incontinence (2010) Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn 29: 213–240. DOI: 10.1002/nau.20870.
2. Andersson K. Martin N. Nitti V. (2013) Selective beta3-adrenoceptor agonists in the treatment of the overactive bladder. J Urol, in press. DOI: 10.1016/j.juro.2013.02.104.
3. Cameron A. P. Heidelbaugh J. B. Masahito J. (2013). Diagnosis and office based treatment of urinary incontinence in adults: part one diagnosis and testing. Therapeutic Advances in Urology. DOI: 10.1177/1756287213489720.
4. Bergman J. Robertson J. Elia G. (2004) Effects of a magnetic field on pelvic floor muscle function in women with stress urinary incontinence. Altern Ther Health Med 10: 70–72.
5. Burgio K. Richter H. Clements R. Redden D. Goode P. (2007) Changes in urinary and fecal incontinence symptoms with weight loss surgery in morbidly obese women. Obstet Gynecol 110: 1034–1040. DOI: 10.1097/01.AOG.0000285483.22898.9c.
6. Cameron A. Haraway A. (2011) The treatment of female stress urinary incontinence: an evidence-based review. Open Access J Urol 3: 109–120.
7. Cody J. Richardson K. Moehrer B. Hextall A. Glazener C. (2009) Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev 4: CD001405. DOI: 10.1002/14651858.CD001405.pub2.
8. Cornu J. Sebe P. Ciofu C. Peyrat L. Cussenot O. Haab F. (2011) Mid-term evaluation of the transobturator male sling for post-prostatectomy incontinence: focus on prognostic factors. BJU Int 108: 236–240. DOI: 10.1111/j.1464–410X.2010.09765.x.
9. Dmochowski R. Blaivas J. Gormley E. Juma S. Karram M. Lightner D. for the Female Stress Urinary Incontinence Update Panel of the American Urological Association Education and Research, Inc. (2010) Update of AUA guideline on the surgical management of female stress urinary incontinence. J Urol 183: 1906–1914. DOI: 10.1016/j.juro.2010.02.2369.
10. Dmochowski R. Miklos J. Norton P. Zinner N. Yalcin I. Bump R. for the Duloxetine Urinary Incontinence Study Group (2003) Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. J Urol 170: 1259–1263. DOI: 10.1097/01.ju.0000080708.87092.cc.
11. Ebell M. Siwek J. Weiss B. Woolf S. Susman J. Ewigman B. (2004) Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. J Am Board Fam Pract 17: 59–67.
12. Eustice S. Roe B. Paterson J. (2000) Prompted voiding for the management of urinary incontinence in adults. Cochrane Database Syst Rev 2: CD002113. DOI: 10.1002/14651858.CD002113.
13. Fader M. Bliss D. Cottenden A. Moore K. Norton C. (2010) Continence products: research priorities to improve the lives of people with urinary and/or fecal leakage. Neurourol Urodyn 29: 640–644. DOI: 10.1002/nau.20918.
14. Fader M. Cottenden A. Getliffe K. (2008) Absorbent products for moderate-heavy urinary and/or faecal incontinence in women and men. Cochrane Database Syst Rev 4: CD007408. DOI: 10.1002/14651858.CD007408.
15. Food and Drug Administration (2011) Urogynecologic Surgical Mesh: Update on the Safety and Effectiveness of Transvaginal Placement for Pelvic Organ Prolapse. Food and Drug Administration.
16. Fowler C. Auerbach S. Ginsberg D. Hale D. Radziszewski P. Rechberger T. (2012) OnabotulinumtoxinA improves health-related quality of life in patients with urinary incontinence due to idiopathic overactive bladder: a 36-week, double-blind, placebo-controlled, randomized, dose-ranging trial. Eur Urol 62: 148–157. DOI: 10.1016/j.eururo.2012.03.005.
17. Gopal M. Haynes K. Bellamy S. Arya L. (2008) Discontinuation rates of anticholinergic medications used for the treatment of lower urinary tract symptoms. Obstet Gynecol 112: 1311–1318. DOI: 10.1097/AOG.0b013e31818e8aa4.
18. Harvey M. Baker K. Wells G. (2001) Tolterodine versus oxybutynin in the treatment of urge urinary incontinence: a meta-analysis. Am J Obstet Gynecol 185: 56–61. DOI: 10.1067/mob.2001.116371.
19. Hay-Smith J. Herbison P. Ellis G. Morris A. (2005) Which anticholinergic drug for overactive bladder symptoms in adults. Cochrane Database Syst Rev 3: CD005429. DOI: 10.1002/14651858.CD005429.
20. Herbison G. Arnold E. (2009) Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults. Cochrane Database Syst Rev 2: CD004202. DOI: 10.1002/14651858.CD004202.pub2.
21. Herbison P. Plevnik S. Mantle J. (2002) Weighted vaginal cones for urinary incontinence. Cochrane Database Syst Rev 1: CD002114. DOI: 10.1002/14651858.CD002114.
22. Herschorn S. Bruschini H. Comiter C. Grise P. Hanus T. Kirschner-Hermanns R. for the Committee of the International Consultation on Incontinence (2010) Surgical treatment of stress incontinence in men. Neurourol Urodyn 29: 179–190. DOI: 10.1002/nau.20844.
23. Hirayama F. Lee A. (2011) Green tea drinking is inversely associated with urinary incontinence in middle-aged and older women. Neurourol Urodyn 30: 1262–1265. DOI: 10.1002/nau.20987.
24. Hu T. Wagner T. Bentkover J. Leblanc K. Zhou S. Hunt T. (2004) Costs of urinary incontinence and overactive bladder in the United States: a comparative study. Urology 63: 461–465.
25. Hunsballe J. Djurhuus J. (2001) Clinical options for imipramine in the management of urinary incontinence. Urol Res 29: 118–125.
26. Jura Y. Townsend M. Curhan G. Resnick N. Grodstein F. (2011) Caffeine intake, and the risk of stress, urgency and mixed urinary incontinence. J Urol 185: 1775–1780. DOI: 10.1016/j.juro.2011.01.003.
27. Kennelly M. Moore R. Nguyen J. Lukban J. Siegel S. (2010) Prospective evaluation of a single incision sling for stress urinary incontinence. J Urol 184: 604–609. DOI: 10.1016/j.juro.2010.04.003.
28. Latthe P. Singh P. Foon R. Toozs-Hobson P. (2010) Two routes of transobturator tape procedures in stress urinary incontinence: a meta-analysis with direct and indirect comparison of randomized trials. BJU Int 106: 68–76. DOI: 10.1111/j.1464–410X.2009.09051.x.
29. Miller J. Ashton-Miller J. DeLancey J. (1998) A pelvic muscle precontraction can reduce cough-related urine loss in selected women with mild SUI. J Am Geriatr Soc 46: 870–874.
30. Miller J. Sampselle C. Ashton-Miller J. Hong G. DeLancey J. (2008) Clarification and confirmation of the Knack maneuver: the effect of volitional pelvic floor muscle contraction to preempt expected stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct 19: 773–782. DOI: 10.1007/s00192-007-0525-3.
31. Moore K. Schieman S. Ackerman T. Dzus H. Metcalfe J. Voaklander D. (2004) Assessing comfort, safety, and patient satisfaction with three commonly used penile compression devices. Urology 63: 150–154.
32. Nitti V. Dmochowski R. Herschorn S. Sand P. Thompson C. Nardo C. for the EMBARK Study Group (2012) OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3 randomized placebo-controlled trial. J Urol, in press. DOI: 10.1016/j.juro.2012.12.022.
33. Nix D. Haugen V. (2010) Prevention and management of incontinence-associated dermatitis. Drugs Aging 27: 491–496. DOI: 10.2165/11315950-000000000-00000.
34. Ostaszkiewicz J. Johnston L. Roe B. (2004) Timed voiding for the management of urinary incontinence in adults. Cochrane Database Syst Rev 1: CD002802. DOI: 10.1002/14651858.CD002802.pub2.
35. Pemberton P. Brooks A. Eriksen C. Frost S. Graham S. Greenman L. (2006) A comparative study of two types of urinary sheath. Nurs Times 102: 36–41.
36. Peters K. Carrico D. Perez-Marrero R. Khan A. Wooldridge L. Davis G. (2010) Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol 183: 1438–1443. DOI: 10.1016/j.juro.2009.12.036.
37. Phelan S. Kanaya A. Subak L. Hogan P. Espeland M. Wing R. for the Look AHEAD Research Group (2012) Weight loss prevents urinary incontinence in women with type 2 diabetes: results from the Look AHEAD trial. J Urol 187: 939–944. DOI: 10.1016/j.juro.2011.10.139.
38. Richter H. Burgio K. Brubaker L. Nygaard I. Ye W. Weidner A. for the Pelvic Floor Disorders Network (2010) Continence pessary compared with behavioral therapy or combined therapy for stress incontinence: a randomized controlled trial. Obstet Gynecol 115: 609–617. DOI: 10.1097/AOG.0b013e3181d055d4.
39. Roberson E. Gould J. Wald A. (2010) Urinary and fecal incontinence after bariatric surgery. Dig Dis Sci 55: 2606–2613. DOI: 10.1007/s10620-010-1190-9.
40. Rossouw J. Anderson G. Prentice R. LaCroix A. Kooperberg C. Stefanick M. for the Writing Group for the Women–s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women–s Health Initiative randomized controlled trial. JAMA 288: 321–333.
41. Saint S. Kaufman S. Rogers M. Baker P. Ossenkop K. Lipsky B. (2006) Condom versus indwelling urinary catheters: a randomized trial. J Am Geriatr Soc 54: 1055–1061. DOI: 10.1111/j.1532–5415.2006.00785.x.
42. Shamliyan T. Kane R. Wyman J. Wilt T. (2008) Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med 148: 459–473.
43. Sirls L. Foote J. Kaufman J. Lightner D. Miller J. Moseley W. (2002) Long-term results of the FemSoft urethral insert for the management of female stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 13: 88–95; discussion 95.
44. Sivaslioglu A. Unlubilgin E. Aydogmus S. Keskin L. Dolen I. (2012) A prospective randomized controlled trial of the transobturator tape and tissue fixation mini-sling in patients with stress urinary incontinence: 5-year results. J Urol 188: 194–199.
45. Subak L. Richter H. Hunskaar S. (2009a) Obesity and urinary incontinence: epidemiology and clinical research update. J Urol 182(6 Suppl.): S2–S7. DOI: 10.1016/j.juro.2009.08.071.
46. Subak L. Wing R. West D. Franklin F. Vittinghoff E. Creasman J. for the PRIDE Investigators (2009b) Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med 360: 481–490. DOI: 10.1056/NEJMoa0806375.
47. Teunissen T. Lagro-Janssen A. (2009) Sex differences in the use of absorbent (incontinence) pads in independently living elderly people: do men receive less care? Int J Clin Pract 63: 869–873. DOI: 10.1111/j.1742–1241.2008.01975.x.
48. Trowbridge E. Fenner D. (2007) Practicalities and pitfalls of pessaries in older women. Clin Obstet Gynecol 50: 709–719. DOI: 10.1097/GRF.0b013e3180d0a4ce.
49. Wallace S. Roe B. Williams K. Palmer M. (2004) Bladder training for urinary incontinence in adults. Cochrane Database Syst Rev 1: CD001308. DOI: 10.1002/14651858.CD001308.pub2.
50. Weiss B. (2005) Selecting medications for the treatment of urinary incontinence. Am Fam Physician 71: 315–322.
51. White W. Mobley J. III Doggweiler R. Dobmeyer-Dittrich C. Klein F. (2009) Incidence and predictors of complications with sacral neuromodulation. Urology 73: 731–735. DOI: 10.1016/j.urology.2008.11.047.
52. Wilson L. Brown J. Shin G. Luc K. Subak L. (2001) Annual direct cost of urinary incontinence. Obstet Gynaecol 98: 398–406.